Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin

Scandinavian Journal of Rheumatology

Volumn 25, Issue 3, 1996, Pages 177-179

  Lesprit, P ^a,b   Mouloud, F ^a   Bierling, P ^a   Schaeffer, A ^a   Cesaro, P ^a   Brun Buisson, C ^a   Godeau, B ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

high dose intravenous immunoglobulin; polyradiculoneuropathy; systemic lupus erythematosus

Indexed keywords

IMMUNOGLOBULIN; PREDNISOLONE;

AGED; ARTICLE; AUTOIMMUNITY; CASE REPORT; DRUG EFFICACY; DRUG SCREENING; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

EID: 0029895373     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609080011     Document Type: Article

References (17)

1. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. A clinical-pathological study of 24 cases and review of the literature. Medicine (Baltimore) 1968; 47: 337-69.
2. Tan EM, Cohen AS, Fries JF. The 1982 revisited criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
3. Sedgwick RP and Von Hagen KO. Neurologic manifestations of lupus erythematosus and periarteritis nodosa: report of 10 cases. Bull Los Angeles Neurol Soc 1948; 13: 129.
4. Heptinstall RH and Sowry GSC. Peripheral neuritis in systemic lupus erythematosus. Brit Med J 1952; 1: 525-7.
5. Bailey AA, Sayre GP and Clark EC. Neuritis associated with systemic lupus erythematosus. Arch Neurol Psychiat 1956; 75: 251-9.
6. Scheinberg L. Polyneuritis in systemic lupus erythematosus. N Engl J Med 1956; 255: 416-8.
7. Goldberg M, Chitanondh H. Polyneuritis with albuminocytologic dissociation in the spinal fluid in systemic lupus erythematosus. Report case with review of pertinent literature. Am J Med 1959; 27: 342-50.
8. Lewis DC. Systemic lupus erythematosus and polyneuropathy. Arch Intern Med 1965; 116: 518-22.
9. McCombe PA, McLeod JG, Pollard JD, Guo YP and Ingall TJ. Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Brain 1987; 110: 533-49.
10. Rechthand E, Cornblath DR, Stern BJ, Meyerhoff JO. Chronic demyelinating polyneuropathy in systemic lupus erythematosus. Neurology Cleveland 1984; 34: 1375-7.
11. Raphael JC, Chastang C, Masson C, Elkharrat D, Goulon M. Guillain-Barre syndrome and plasma exchange. Lancet 1985; 2: 45.
12. Vermeulen M, van der Meché FGA, Speelman JD, Weber A, Busch HFM. Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci 1985; 70: 317-26.
13. van der Meché FGA, Schmitz PIM, Guillain-Barre Study Group. A randomized trial comparing immune globulin and plasma exchange in Guillain-Barre syndrome. N Engl J Med 1992; 326: 1123-9.
14. Maier WP, Gordon DS, Howard RF, et al. Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia. Arthritis Rheum 1990; 33: 1233-9.
15. Zeuner RA, Schroeder JO, Schröder F, Euler HH. Successful application of high dose intravenous immunoglobulins in Sjögren's syndrome associated arthritis. Ann Rheum Dis 1995; 54: 936.
16. Richter C, Schnabel A, Csernok E, de Groot K, Reinhold-Keller E, Gross L. Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol 1995; 101: 2-7.
17. Sultan Y, Kazatchkine MD, Nydegger U, et al. Intravenous immunoglobulins in the treatment of spontaneously acquired Factor VIII-C inhibitors. Am J Med 1991; 55(a): 355-9.